Cargando…
Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer’s Disease Dementia
Soluble oligomeric assemblies of amyloid β-protein (Aβ), called Aβ oligomers (AβOs), have been recognized as primary pathogenetic factors in the molecular pathology of Alzheimer’s disease (AD). AβOs exert neurotoxicity and synaptotoxicity and play a critical role in the pathological progression of A...
Autores principales: | Araki, Wataru, Kametani, Fuyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773221/ https://www.ncbi.nlm.nih.gov/pubmed/35052635 http://dx.doi.org/10.3390/antiox11010132 |
Ejemplares similares
-
Reversibility of Aβ oligomer neurotoxicity
por: Araki, Wataru
Publicado: (2017) -
Amyloid β-protein oligomers upregulate the β-secretase, BACE1, through a post-translational mechanism involving its altered subcellular distribution in neurons
por: Mamada, Naomi, et al.
Publicado: (2015) -
The neurotoxicity of amyloid β-protein oligomers is reversible in a primary neuron model
por: Tanokashira, Daisuke, et al.
Publicado: (2017) -
Mutations in the β-amyloid precursor protein in familial Alzheimer’s disease increase Aβ oligomer production in cellular models
por: Ohshima, Yoichi, et al.
Publicado: (2018) -
Small molecule-mediated co-assembly of amyloid-β oligomers reduces neurotoxicity through promoting non-fibrillar aggregation
por: Liu, Hao, et al.
Publicado: (2020)